Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYANOTECH CORPCYAN · Entity 8431 | CFO, VP Fin & Admin | July 30, 2020 | August 03, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYANOTECH CORP
Report date July 30, 2020 · Filed August 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,786 |
Reported balance
After 2020-07-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-07-30 · Grant · Acquired 1,686 · Balance 1,786 F1: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2: The restricted stock units shall vest as to 33 shares on April 6, 2021; 562 shares on July 30, 2021; 33 shares on April 6, 2022; 562 shares on July 30, 2022; 34 shares on April 6, 2023; and 562 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock.
F2: The restricted stock units shall vest as to 33 shares on April 6, 2021; 562 shares on July 30, 2021; 33 shares on April 6, 2022; 562 shares on July 30, 2022; 34 shares on April 6, 2023; and 562 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 30, 2020 Filed Aug 3, 2020 17:23 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted Stock Units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-016338 · rdgdoc.xml · derivative · entry 1 ORLOPP BRIAN BRETT · CIK 0001764215 · CFO, VP Fin & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,786 Underlying: Common Stock · 1,686 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 562 shares on July 30, 2021; 33 shares on April 6, 2022; 562 shares on July 30, 2022; 34 shares on April 6, 2023; and 562 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 562 shares on July 30, 2021; 33 shares on April 6, 2022; 562 shares on July 30, 2022; 34 shares on April 6, 2023; and 562 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:20 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007346 · rdgdoc.xml · derivative · entry 3 ORLOPP BRIAN BRETT · CIK 0001764215 · CFO, VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:20 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 13 | $2.07 | $26.91 |
DisclosureSEC source: 0001437749-20-007346 · rdgdoc.xml · nonDerivative · entry 2 ORLOPP BRIAN BRETT · CIK 0001764215 · CFO, VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20 F2 · kind: No stock was sold. In connection with the vesting of the 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:20 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007346 · rdgdoc.xml · nonDerivative · entry 1 ORLOPP BRIAN BRETT · CIK 0001764215 · CFO, VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 05, 2019 Filed Jul 10, 2019 16:52 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-013768 · rdgdoc.xml · derivative · entry 1 ORLOPP BRIAN BRETT · CIK 0001764215 · CFO, VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33 Underlying: Common Stock · 33 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 5, 2020, subject to the reporting person's continued service with Cyanotech on the vesting date. F2 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 5, 2020, subject to the reporting person's continued service with Cyanotech on the vesting date. Read SEC document |
| January 03, 2019 Filed Jan 11, 2019 15:06 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantCyanotech common stock options · Derivative | 50,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001437749-19-000717 · rdgdoc.xml · derivative · entry 1 ORLOPP BRIAN BRETT · CIK 0001764215 · CFO, VP, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Cyanotech common stock · 50,000 shares Expires 2029-01-03 F1 · derivative.exercise_date: The stock options shall vest as to 12,500 shares on January 3, 2020, 12,500 shares on January 3, 2021, 12,500 shares on January 3, 2022 and 12,500 shares on January 3, 2023, in each case subject to continued service with Cyanotech on the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.